LakeShore Biopharma Co Ltd

LSBCF
$0.07 (+ $0.00 + 0.00%)
Last updated: Previous Close (2026-07-28)
LSBCF Metrics
Exchange
🇺🇸 NASDAQ XNGS
Nasdaq/NGS (Global Select Market)United StatesAmerica/New_York
SectorHealth Care
IndustryBiotechnology
ISINKYG9845F2080
Market Price0.07
Dividend Yield N/A
Dividend Growth
1YN/A
3YN/A
5YN/A
10YN/A
Annual Dividend N/A
Latest Payout ($)N/A
Latest Payout DateN/A
Dividend FrequencyNone
P/E RatioN/A
EPSN/A
Market Cap$2.8M
Book Value3.55
Price to Book0.019
BetaN/A
52w High1.48
52w Low0.03
Next Earnings DateN/A

LakeShore Biopharma Co Ltd trades under ticker LSBCF on NASDAQ as a stock. Use this page to review stock price, share price, dividends, and price history. The page also shows Health Care exposure. Identifiers: ISIN KYG9845F2080. Also searched as LakeShore Biopharma.

Related researchLSBCF stock priceLSBCF share priceLakeShore Biopharma stockLakeShore Biopharma share price
About the Company
LakeShore Biopharma Co., Ltd, a biopharmaceutical company, discovers, develops, manufactures, commercializes, and sells vaccines and therapeutic biologics for infectious diseases and cancer. Its product pipeline includes YSJA, a conventional rabies vaccine, which is in marketed stage; PIKA, a rabies vaccine, which is in phase I/III and preclinical trials for the treatment of rabies virus; PIKA YS-ON-001, an immuno-oncology therapeutic candidate that is in phase I trial for the treatment of pancreatic and hepatocellular cancer; PIKA YS-HBV-001, a hepatitis B vaccine, which is in phase I trial; PIKA YS-HBV-002, an immune-therapy vaccine that is in preclinical trial for the treatment of chronic HBV infection; and PIKA YS-ON-001 and PIKA Influenza Vaccine, which are in preclinical trials. The company was formerly known as YS Biopharma Co., Ltd. and changed its name to LakeShore Biopharma Co., Ltd in May 2024. LakeShore Biopharma Co., Ltd was founded in 1994 and is based in Beijing, China.
Price History